How Glaxo marketed an ailment

How Glaxo marketed an ailment

By Jeanne Whalen

The Wall Street Journal Europe

25 Oct 2006



WHEN DRUG GIANT GlaxoSmithKline PLC launched a new medicine for restless-legs syndrome last year, few people had heard of the aff liction, and some physicians were skeptical that it even existed. Today, the drug, Requip, is on track to post sales of... read more...

Tech Tags: The Wall Street Journal Europe newspaper Front Page

Coping with antidepressants

Coping with antidepressants

Tuesday - Health
03 Oct 2006

Depression is one of the easiest conditions for psychiatrists to treat, compared with all the other conditions they have to deal with. That’s the view of American psychiatrist and author Dr Peter Breggin, who will be in Dublin later this month to speak... read more...

Tech Tags: Tuesday - Health newspaper YourLifestyle